FAKTOR-OPTIONSSCHEIN - ASTRAZENECA | Market Closed - Börse Stuttgart 10:49:42 2024-06-28 EDT | ||
| 24.48 EUR | -6.17% |
|
| Current month | +13.44% | ||
| 1 month | +4.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 24.48 | -6.17% |
| 24-06-27 | 26.09 | -4.89% |
| 24-06-26 | 27.43 | -0.76% |
| 24-06-25 | 27.64 | +4.11% |
| 24-06-24 | 26.55 | +4.49% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 10:49 am
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | Morgan Stanley |
| WKN | MG1UY1 |
| ISIN | DE000MG1UY10 |
| Date issued | 2024-04-08 |
| Strike | 10,790 p |
| Maturity | Unlimited |
| Parity | 0.78 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 29.83 € |
|---|---|
| Lowest since issue | 9.48 € |
| Spread | 0.07 € |
| Spread % | 0.29% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
156.2
USD
Average target price
174.4
USD
Spread / Average Target
+11.69%
- Stock Market
- Certificates
- Certificat
